Citi Maintains $26 Price Target On Holigic

According to Citi, Hologic HOLX posted a positive F3Q11 with revs above Street and EPS in-line with Street. Citi said that F2011E EPS maintained at $1.26. “We will maintain target price at $26 based on an unchanged 17x P/E on our C2012E EPS of $1.50.” Hologic closed yesterday at $18.05.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsCitiHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!